(Q38703934)

5 September 2017

title

The challenges of lupus anticoagulants (English)

1 reference

Cecilia Beatrice Chighizola

5 September 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26789237%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Pier Luigi Meroni

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26789237%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Elena Raschi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26789237%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Maria Orietta Borghi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26789237%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

5

Vittorio Pengo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26789237%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Alessandra Banzato

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26789237%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

20 January 2016

1 reference

Expert Review of Hematology

5 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26789237%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26789237%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26789237%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

389-400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26789237%20AND%20SRC:MED&resulttype=core&format=json

The paradox of the lupus anticoagulant: history and perspectives.

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Antiphospholipid antibody testing and standardization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Clinical course of high-risk patients diagnosed with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Immunological and molecular analysis of three monoclonal lupus anticoagulant antibodies from a patient with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

New tests to detect antiphospholipid antibodies: anti-domain I beta-2-glycoprotein-I antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

The effect of phospholipids on the formation of immune complexes between autoantibodies and beta2-glycoprotein I or prothrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Guidelines on the investigation and management of antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Commonalities and contrasts in recent guidelines for lupus anticoagulant detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Silica clotting time (SCT) as a screening and confirmatory test for detection of the lupus anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Heterogeneity of Russell's viper venom affects the sensitivity of the dilute Russell's viper venom time to lupus anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Conceptions and misconceptions in testing for lupus anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica-based reagent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

A simple method to discriminate between beta2-glycoprotein I- and prothrombin-dependent lupus anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

A two-step coagulation test to identify antibeta-glycoprotein I lupus anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Mixing studies in lupus anticoagulant testing are required at least in some type of samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Screening for lupus anticoagulants in patients treated with vitamin K antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Laboratory identification of lupus anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Acquired immune-mediated thrombophilia in lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.2016.1140034

10.1586/17474086.2016.1140034

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26789237%20AND%20SRC:MED&resulttype=core&format=json

release_oqjrdirzzfckpc2orfm4mdjon4

11 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oqjrdirzzfckpc2orfm4mdjon4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference